Selegiline (E250)

790  relevant articles (87 outcomes, 192 trials/studies) found for this Drug

E250; Jumex; E 250; Deprenyl; E-250; Eldepryl; Bristol-Myers Squibb Brand of Selegiline; Emsam; Humex; L-Deprenyl; Selegiline Hydrochloride; Selegiline Hydrochloride, (R)-Isomer; Selegiline Hydrochloride, (R,S)-Isomer; Selegiline Hydrochloride, (S)-Isomer; Selegiline, (R)-Isomer; Selegiline, (R,S)-Isomer; Selegiline, (S)-Isomer; Selegyline; Valeant Brand of Selegiline; Yumex; Zelapar; Bristol Myers Squibb Brand of Selegiline; Hydrochloride, Selegiline; Selegiline Valeant Brand; Deprenalin; Deprenil; Benzeneethanamine, N,alpha-dimethyl-N-2-propynyl-, (R)-

Relationship Network

Drug Context: Research Results

Experts

1.	Amsterdam, Jay D: 5 articles (01/2008 - 02/2003)
2.	Robinson, Donald S: 4 articles (01/2008 - 09/2006)
3.	Birks, J: 3 articles (01/2003 - 01/2000)
4.	Sivenius, J: 3 articles (02/2001 - 01/2000)
5.	Frampton, James E: 2 articles (01/2007 - 01/2007)
6.	Heinonen, E: 2 articles (04/2006 - 01/2001)
7.	Moonsammy, George: 2 articles (12/2007 - 01/2007)
8.	Stevens, S Y: 2 articles (09/2000 - 09/2000)
9.	Akhondzadeh, Shahin: 2 articles (03/2008 - 08/2003)
10.	Yang, Ying: 2 articles (12/2007 - 01/2007)

Related Diseases

1.	Parkinson Disease (Parkinson's Disease) 05/01/2003 - "Deprenyl and other propargylamines are clinically beneficial in Parkinson's disease (PD)" 01/01/1989 - "In order to evaluate in a double-blind manner the therapeutic efficacy of selegiline in the treatment of late-phase Parkinson's disease, 19 patients with end-of-dose type fluctuations were randomized for a double-blind cross-over trial receiving either selegiline 10 mg or placebo" 01/01/1989 - "According to the present results selegiline monotherapy seems to have therapeutic efficacy in the early phase of Parkinson's disease" 01/01/1987 - "It has recently been suggested that deprenyl might be effective in altering the course of Parkinson's disease by actually slowing its progression" 01/01/1986 - "Overall, (-)deprenyl was effective in the treatment of our parkinsonian patients in the various conditions evaluated, and thus constitutes a new therapeutic strategy for Parkinson's disease." Get all the results and reference details, order at left...
2.	Alzheimer Disease (Alzheimer's Disease) 09/01/1992 - "Maintenance on (-)deprenyl significantly improved the performance of patients with Alzheimer's disease" 01/01/2003 - "The efficacy of selegiline for symptoms of Alzheimer's disease remains controversial and is reflected by its low rate of prescription and the lack of approval by several regulatory authorities in Europe and elsewhere" 01/01/2000 - "The efficacy of selegiline for symptoms of Alzheimer's disease remains controversial and is reflected by its low rate of prescription and the lack of approval by several regulatory authorities in Europe and elsewhere" 11/01/2006 - "In Alzheimer's disease, short term studies of selegiline suggest a beneficial effect; whereas long term studies are less convincing." 02/01/2002 - "The effect of selegiline in the treatment of people with Alzheimer's disease: a meta-analysis of published trials." Get all the results and reference details, order at left...
3.	Dyskinesias (Dyskinesia) 01/01/2004 - "When selegiline was stopped after 9 years of treatment, abnormal involuntary movements improved to pretreatment level and psychiatric behaviour returned to normal" 01/01/1994 - "Adjunctive therapy benefited all dyskinesia types, although the majority of patients (12/17) helped by selegiline had LDD or LDC" 01/01/1987 - "Peak-dose dyskinesias tended to increase with selegiline while biphase and off-period involuntary movements improved in some cases" 05/01/2005 - "Selegiline was reassigned as Non-efficacious for the prevention of dyskinesias" 04/01/2004 - "The average number of dyskinesia-free on hours for the Zydis selegiline patients increased by 1.8 hours at Week 12" Get all the results and reference details, order at left...
4.	Parkinsonian Disorders (Parkinsonism) 01/01/1987 - "Therapeutic efficacy of R-(-)-deprenyl as adjuvant therapy in advanced parkinsonism." 01/01/1983 - "In a limited trial, deprenyl has produced promising results during this phase of parkinsonism" 01/01/1993 - "These results show that selegiline is safe and effective as monotherapy in early parkinsonism" 01/01/1993 - "The French Selegiline Multicenter Trial was carried out in 1990 to investigate whether the disability of de novo patients with parkinsonism could be improved during the first 3 months by monotherapy with selegiline (10 mg/day)" 03/14/2006 - "The authors present advantages and limitations of futility designs along with examples derived from the data archive of a large Phase III efficacy study of treatments to delay PD progression, the Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism (DATATOP) trial" Get all the results and reference details, order at left...
5.	Neurodegenerative Diseases (Neurodegenerative Disease) 11/01/2006 - "Therapeutic efficacy of selegiline in neurodegenerative disorders and neurological diseases." 03/01/2002 - "Prophylactic use of low doses of l-deprenyl may accord protection against vascular and neurodegenerative diseases associated with aging." 07/15/1998 - "L-deprenyl protects neurons in a number of in vivo and in vitro models and it has been postulated that it ameliorates some neurodegenerative disorders" 01/01/2006 - "This study suggests the potential use of combined selegiline and stem cell therapy to improve deficits in neurodegenerative diseases in aging." 10/01/1993 - "This study indicates therefore that (-)-deprenyl may be useful for regulating astrogliosis following CNS injury as well as in some neurodegenerative diseases." Get all the results and reference details, order at left...
148 Diseases and 790 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Selegiline (E250)
2.	Monoamine Oxidase (MAO)
3.	Levodopa (L Dopa)
4.	Vitamin E
5.	Bromocriptine (Parlodel)
6.	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)
7.	Tablets
8.	Sinemet (Nakom)
9.	Dopamine (Intropin)
10.	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)
261 Drugs and Important Bio-Agents and 538 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Activities of Daily Living (ADL)
2.	Hormone Replacement Therapy (Therapy, Hormone Replacement)
3.	Sympathectomy (Sympathectomies)
4.	Drug Therapy (Chemotherapy)
5.	Transplants (Transplant)
10 Therapies and Procedures and 17 more articles analyzed in the Research Interface, order at left...